Purpose:
To advocate for the MedTech industry with relevant stakeholders across the key areas in healthcare policy, reimbursement, regulatory, industry development and sustainability. The Committee provides oversight of Reimbursement, Industry Policy subcommittees for coordinated and aligned strategies and communications.
Objectives:
- Oversee the execution of the Advocacy Strategy and its activities, including active stakeholder engagement to promote the policy priorities of the industry and the strategic issues identified by the subcommittees,
- Provide strategic counsel and shared intelligence, and
- Support the amplification of advocacy content through direct engagement.
MTAA Lead: Matthew Versi, Director, External Affairs and Communications
Member Name | Position Title | Company |
|---|---|---|
| Pat Williams (Chair and Board Representative) | Vice President & Country Manager, ANZ & Korea | Edwards Lifesciences Pty Ltd |
| James Doyle (Board Representative) | Senior Director – Foot & Ankle, Spine and Trauma | Stryker Australia Pty Ltd |
| Kate King | Government Affairs Director, ANZ | Medtronic Australasia Pty Ltd |
| Michael Simmonds | Director, Health Economics & Government Affairs | Boston Scientific Pty Ltd |
| Clinton Lubcke | Senior Manager, Government Affairs | Stryker Australia Pty Ltd |
| Robyn Chu | Head of Market Access & Policy | Alcon Laboratories (Australia) Pty Ltd |
| Daniel Kildea | Director, Government Affairs & Policy | Johnson & Johnson MedTech |
| Ofer Elboher | General Manager, Abbott Medical (Electrophysiology) | Abbott Medical Australia Pty Ltd |
| Colm O'Rourke | General Manager | MDSS AU Pty Ltd |
| Kristy Hardy | Director Health Economics and Market Access | Johnson & Johnson MedTech |
| Mahesh Datar | Senior Manager, Regulatory Affairs | Medtronic Australasia Pty Ltd |
